Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial

A previous pilot study with rituximab, gemcitabine and oxaliplatin showed promising activity in patients with refractory/relapsed B-cell lymphoma. We, therefore, conducted a phase II study to determine whether these results could be reproduced in a multi-institutional setting. This phase II study in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mounier, Nicolas, El Gnaoui, Taoufik, Tilly, Hervé, Canioni, Danièle, Sebban, Catherine, Casasnovas, René-Olivier, Delarue, Richard, Sonet, Anne, Beaussart, Pauline, Petrella, Tony, Castaigne, Sylvie, Bologna, Serge, Salles, Gilles, Rahmouni, Alain, Gaulard, Philippe, Haioun, Corinne
Formato: Artigo
Idioma:Inglês
Publicado: Ferrata Storti Foundation 2013
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3815173/
https://ncbi.nlm.nih.gov/pubmed/23753028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.090597
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares